top of page

Defining the Biggest and Most
Complex Industry in Human History


poltiics cover.png
Biomarkers of Human Longevity with shadow.png
Longevity Industry 2.0 ra.png

Longevity Technocracy, Modern Approaches to Policy, Governance and National Industrial Strategies, and Longevity as the New Political Priority of the 21st Century

Data Science for Accelerating Aging Research and R&D, The Critical Catalyst for Practical Human Longevity, Tangible Investment Decision-Making and De-Risking

DeepTech Engineering
The Accelerated Trajectory of Human Longevity: The Blueprint and Pathway
from Longevity Industry 1.0 to 2.0

  • LinkedIn
  • Twitter
  • YouTube
  • Instagram
PL Book Cover.png
Longevity Financial Industry with shadow.png

The Complete Guide on
How to Celebrate
Your 123rd Birthday

Health as New Wealth. Longevity FinTech, WealthTech, InvestTech, InsurTech, AgeTech and the Coming Rise of Longevity Banks, Investment Banks, Stock Exchanges, ETFs, Indices, Novel Financial Instruments and Derivatives

Women Longevity - V2.png

Women Longevity, Female Health,
the Rise of FemTech and Why the Future Health and Wealth of Humanity (on Earth and Beyond)
Depends on Female Longevity

About the Author

Dmitry Kaminskiy is an innovative entrepreneur, investor, author and philanthropist dedicated to impact investment and ethical business, with a focus on engineering the accelerated trajectory of progressive technological development for the benefit of humanity.


Mr. Kaminskiy is a co-founder and managing partner of Deep Knowledge Group - a consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, Precision Medicine, FinTech, GovTech, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, policy and philanthropy.


  • He leads the activities of the consortium’s venture arms - Deep Knowledge Ventures, an investment fund focused on DeepTech and advanced science projects, and Longevity.Capital, which prioritizes the convergence of Longevity and Artificial Intelligence, areas in which it has unparalleled investment   and  exit  strategies.

  • He is a frequent speaker on the topics of AI and Longevity, including conferences organized in London by The Economist “Aging Societies and The Business of Longevity”, Financial Times “Smart Machines vs Smart People”, at the Future Finance Forum in Seoul “AI in Finance”, “Precision Medicine World Conference" in Silicon Valley, as well as several others at Oxford and Cambridge Universities. 

Mr. Kaminskiy serves as managing trustee of Biogerontology Research Foundation, the UK’s oldest Longevity focused charity.

bottom of page